Han Li

2.8k total citations
93 papers, 1.1k citations indexed

About

Han Li is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Han Li has authored 93 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Surgery, 27 papers in Oncology and 17 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Han Li's work include Hepatocellular Carcinoma Treatment and Prognosis (10 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Cancer Cells and Metastasis (6 papers). Han Li is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (10 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Cancer Cells and Metastasis (6 papers). Han Li collaborates with scholars based in China, United States and Germany. Han Li's co-authors include Wenqiang Cao, Jiayun Zhang, Hong Liu, Jingyi Li, Xiaodong Ren, Lei Tian, Chengyuan Liang, Minyi Jia, Ke Su and Betty Yuen Kwan Law and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Han Li

84 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Han Li China 17 331 204 197 172 142 93 1.1k
Wenting Li China 21 446 1.3× 153 0.8× 179 0.9× 102 0.6× 185 1.3× 89 1.4k
Shichao Li China 20 613 1.9× 221 1.1× 177 0.9× 306 1.8× 136 1.0× 82 1.5k
Hai Zhu China 20 547 1.7× 135 0.7× 129 0.7× 258 1.5× 112 0.8× 64 1.2k
Zhao Zhang China 23 723 2.2× 203 1.0× 189 1.0× 118 0.7× 78 0.5× 73 1.4k
Yingchun Xu China 18 421 1.3× 493 2.4× 222 1.1× 220 1.3× 131 0.9× 75 1.2k
Hong Gao China 15 385 1.2× 190 0.9× 104 0.5× 215 1.3× 211 1.5× 59 1.1k
Hongzhi Xu China 19 808 2.4× 197 1.0× 108 0.5× 354 2.1× 145 1.0× 51 1.4k
Ziying Zhang China 16 545 1.6× 305 1.5× 113 0.6× 96 0.6× 139 1.0× 74 1.1k
Xueping Wang China 23 353 1.1× 428 2.1× 279 1.4× 267 1.6× 210 1.5× 83 1.3k

Countries citing papers authored by Han Li

Since Specialization
Citations

This map shows the geographic impact of Han Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Han Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Han Li more than expected).

Fields of papers citing papers by Han Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Han Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Han Li. The network helps show where Han Li may publish in the future.

Co-authorship network of co-authors of Han Li

This figure shows the co-authorship network connecting the top 25 collaborators of Han Li. A scholar is included among the top collaborators of Han Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Han Li. Han Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Han, et al.. (2025). Comparison in trends and outcomes of multiple vs. single arterial coronary bypass graft surgery. Frontiers in Cardiovascular Medicine. 12. 1661006–1661006.
2.
3.
4.
Xie, Fei, Xiaohu Wen, Ruping Zhao, et al.. (2024). GSTA1/CTNNB1 axis facilitates sorafenib resistance via suppressing ferroptosis in hepatocellular carcinoma. Pharmacological Research. 210. 107490–107490. 9 indexed citations
5.
Li, Han, Hui Zhou, Chenfei Hu, et al.. (2024). Preoperative Short-Course Radiotherapy Followed by Chemotherapy and PD-1 Inhibitor Administration for Locally Advanced Rectal Cancer: The Initial Results of a Randomized Phase II/III Trial (STELLAR II study). International Journal of Radiation Oncology*Biology*Physics. 120(2). e462–e462. 1 indexed citations
6.
Zhang, Yuwen, Li Zhao, Jiannan Wu, et al.. (2024). 171P A phase II study of ABSK-011 plus atezolizumab in patients with advanced hepatocellular carcinoma (HCC). Annals of Oncology. 35. S78–S78. 1 indexed citations
7.
8.
Li, Han, Bo Yang, Chenjie Wang, et al.. (2024). Construction of an interpretable model for predicting survival outcomes in patients with middle to advanced hepatocellular carcinoma (≥5 cm) using lasso-cox regression. Frontiers in Pharmacology. 15. 1452201–1452201. 3 indexed citations
9.
Xu, Liya, Xiaohua Li, Min Xu, et al.. (2023). P2.14-06 A Phase II Trial Assessing the Safety and Efficacy of Tislelizumab Combined with Chemotherapy and Autologous NK Cells in Patients with ES-SCLC. Journal of Thoracic Oncology. 18(11). S373–S373. 1 indexed citations
10.
11.
Cooper, Adam, Vladimir Andelkovic, Kate Wilkinson, et al.. (2023). 700P First-in-human dose-escalating study of ABSK043, a novel and oral small-molecule inhibitor of PD-L1, in patients with advanced solid tumors. Annals of Oncology. 34. S487–S487. 2 indexed citations
12.
Luo, Fan, Han Li, Wenjuan Ma, et al.. (2023). The BCL-2 inhibitor APG-2575 resets tumor-associated macrophages toward the M1 phenotype, promoting a favorable response to anti-PD-1 therapy via NLRP3 activation. Cellular and Molecular Immunology. 21(1). 60–79. 37 indexed citations
13.
Liu, Hui, Zhao Li, Han Li, et al.. (2023). Serial Cardiac MRI for Quantification of the Dynamics of Anthracycline‐Induced Subclinical Myocardial Injury. Journal of Magnetic Resonance Imaging. 58(5). 1533–1541. 1 indexed citations
14.
Li, Han, Dongmei Han, Weiwei Mao, et al.. (2023). Risk factors of osteoporosis in elderly inpatients: A cross-sectional single-centre study. SHILAP Revista de lepidopterología. 4. 1126172–1126172. 8 indexed citations
15.
Su, Ke, Tao Gu, Ke Xu, et al.. (2023). Construction and validation of a nomogram for HBV-related hepatocellular carcinoma: A large, multicenter study. Annals of Hepatology. 28(4). 101109–101109. 30 indexed citations
16.
Wang, Xiaolong, et al.. (2023). Microsurgical anatomical vascular study of the PICA-PICA bypass. Clinical Neurology and Neurosurgery. 229. 107759–107759. 1 indexed citations
17.
Xu, Yingkun, Han Li, Zhenrong Tang, et al.. (2022). Cuprotosis-Related Genes: Predicting Prognosis and Immunotherapy Sensitivity in Pancreatic Cancer Patients. Journal of Oncology. 2022. 1–15. 17 indexed citations
18.
Ding, Yinan, Ming Xue, Qiusha Tang, et al.. (2022). Immunotherapy-based novel nanoparticles in the treatment of gastrointestinal cancer: Trends and challenges. World Journal of Gastroenterology. 28(37). 5403–5419. 11 indexed citations
19.
Jiang, Tao, Shaocheng Lyu, Lin Zhou, et al.. (2021). Carbohydrate antigen 19-9 as a novel prognostic biomarker in distal cholangiocarcinoma. World Journal of Gastrointestinal Surgery. 13(9). 1025–1038. 1 indexed citations
20.
Yang, Liu, et al.. (2020). SGK2 is overexpressed in colon cancer and promotes epithelial-mesenchymal transition in colon cancer cells. European Journal of Surgical Oncology. 46(10). 1912–1917. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wenting Li Breakdown of academic impact, for papers by Shichao Li Breakdown of academic impact, for papers by Hai Zhu Breakdown of academic impact, for papers by Zhao Zhang Breakdown of academic impact, for papers by Yingchun Xu Breakdown of academic impact, for papers by Hong Gao Breakdown of academic impact, for papers by Hongzhi Xu Breakdown of academic impact, for papers by Ziying Zhang Breakdown of academic impact, for papers by Xueping Wang
Rankless by CCL
2026